A peptide neurotransmitter
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

α-NAAG

Item No. 33337

Technical Information
Formal Name
N-acetyl-α-L-aspartyl-L-glutamic acid
CAS Number
3106-85-2
Synonyms
  • NAAG
  • N-Acetylaspartylglutamic Acid
  • α-Spaglumic Acid
Molecular Formula
C11H16N2O8
Formula Weight
Purity
≥95%
A solid
DMF: 20 mg/mlDMSO: 20 mg/mlEthanol: 20 mg/mlPBS (pH 7.2): 10 mg/ml
SMILES
OC(CC[C@@H](C(O)=O)NC([C@@H](NC(C)=O)CC(O)=O)=O)=O
InChi Code
InChI=1S/C11H16N2O8/c1-5(14)12-7(4-9(17)18)10(19)13-6(11(20)21)2-3-8(15)16/h6-7H,2-4H2,1H3,(H,12,14)(H,13,19)(H,15,16)(H,17,18)(H,20,21)/t6-,7-/m0/s1
InChi Key
OPVPGKGADVGKTG-BQBZGAKWSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    α-NAAG is a peptide neurotransmitter that is widely expressed throughout mammalian central and peripheral nervous systems.1 Following synaptic release, α-NAAG activates postsynaptic metabotropic glutamate receptor 3 (mGluR3) to inhibit cAMP production in neurons and astrocytes, as well as acts on presynaptic mGluR3 to inhibit the release of amine neurotransmitters, including GABA and glutamate.1,2 Increasing α-NAAG levels via NAAG peptidase inhibition reduces trauma-induced excitotoxic cell death in a mouse model of traumatic brain injury, as well as reduces hyperalgesia in various rodent pain models and schizophrenia-like stereotypic behaviors induced by phencyclidine in rats.1 Tumor levels of α-NAAG are positively correlated with tumor grade in patients with gliomas and meningiomas.3

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Neale, J.H., Olszewski, R.T., Gehl, L.M., et alThe neurotransmitter N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophrenia. Trends Pharmacol. Sci. 26(9), 477-484 (2005).

    2. Neale, J.H., Olszewski, R.T., Zuo, D., et alAdvances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide family. J. Neurochem. 118(4), 490-498 (2011).

    3. Nguyen, T., Kirsch, B.J., Asaka, R., et alUncovering the role of N-Acetyl-Aspartyl-Glutamate as a glutamate reservoir in cancer. Cell Rep. 27(2), 491-501 (2019).